Global assessment measures for assessing efficacy in dementia drug trials.

about

Global assessment measures for assessing efficacy in dementia drug trials.

Item

http://www.wikidata.org/entity/Q36806629

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Global assessment measures for assessing efficacy in dementia drug trials.

@ast

Global assessment measures for assessing efficacy in dementia drug trials.

@en

type

Item

label

Global assessment measures for assessing efficacy in dementia drug trials.

@ast

Global assessment measures for assessing efficacy in dementia drug trials.

@en

prefLabel

Global assessment measures for assessing efficacy in dementia drug trials.

@ast

Global assessment measures for assessing efficacy in dementia drug trials.

@en

P1476

Global assessment measures for assessing efficacy in dementia drug trials.

@en

P2093

Kenneth Rockwood

http://www.w3.org/2001/XMLSchema#string

P2860

Attainment of treatment goals by people with Alzheimer's disease receiving galantamine: a randomized controlled trial.

Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials.

The Gottfries-Bråne-Steen scale: validity, reliability and application in anti-dementia drug trials.

Review of outcome measurement instruments in Alzheimer's disease drug trials: psychometric properties of global scales.

Clinical dementia rating training and reliability in multicenter studies: the Alzheimer's Disease Cooperative Study experience.

Improving clinical descriptions to understand the effects of dementia treatment: consensus recommendations.

Goal setting and attainment in Alzheimer's disease patients treated with donepezil.

The treatment of Alzheimer's disease: success short of cure.

Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer's disease.

Ginkgo biloba compared with cholinesterase inhibitors in the treatment of dementia: a review based on meta-analyses by the cochrane collaboration.

P304

S52-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/S0317167100005576

http://www.w3.org/2001/XMLSchema#string

P478

34 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

2007-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17469683

http://www.w3.org/2001/XMLSchema#string